Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Глаксосмитклайн ЛлсfiledCriticalГлаксосмитклайн Ллс
Priority claimed from PCT/US2009/062163external-prioritypatent/WO2010062578A1/en
Publication of UA103208C2publicationCriticalpatent/UA103208C2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R, R, R, R, R, R, Q, Z, and p are as described herein. Compounds of the present invention are useful for the treatment of cancers., (I)
UAA201106674A2008-10-272009-10-272-[(5-chloro-2-{[3-methyl-1-(1-methylethyl)-1h-pyrazol-5-yl]amino}-4-pyridinyl)amino]-n-methylbenzamide as focal adhesion kinase (fak) inhibitor
UA103208C2
(en)